GFP
DGX icon

Gryphon Financial Partners’s Quest Diagnostics DGX Stock Holding History

Gryphon Financial Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Buy
1,861
+48
+3% +$9.42K 0.03% 266
2026
Q1 		$355K Sell
1,813
-11
-0.6% -$2.14K 0.04% 262
2025
Q4 		$317K Buy
1,824
+32
+2% +$5.83K 0.03% 261
2025
Q3 		$341K Sell
1,792
-52
-3% -$9.23K 0.04% 240
2025
Q2 		$331K Sell
1,844
-122
-6% -$21.2K 0.04% 236
2025
Q1 		$333K Buy
1,966
+10
+0.5% +$1.64K 0.05% 209
2024
Q4 		$295K Sell
1,956
-51
-3% -$7.93K 0.04% 211
2024
Q3 		$312K Sell
2,007
-6
-0.3% -$896 0.04% 218
2024
Q2 		$276K Buy
2,013
+37
+2% +$5.07K 0.04% 232
2024
Q1 		$263K Sell
1,976
-284
-13% -$36.8K 0.04% 222
2023
Q4 		$314K Buy
2,260
+223
+11% +$29.3K 0.06% 187
2023
Q3 		$248K Sell
2,037
-185
-8% -$24.6K 0.06% 159
2023
Q2 		$312K Buy
2,222
+47
+2% +$6.48K 0.07% 144
2023
Q1 		$308K Buy
2,175
+62
+3% +$8.87K 0.07% 148
2022
Q4 		$331K Sell
2,113
-19
-0.9% -$2.73K 0.08% 143
2022
Q3 		$262K Sell
2,132
-569
-21% -$74.9K 0.07% 161
2022
Q2 		$359K Sell
2,701
-469
-15% -$63.9K 0.09% 128
2022
Q1 		$433K Sell
3,170
-2,328
-42% -$324K 0.09% 127
2021
Q4 		$951K Buy
5,498
+3,328
+153% +$506K 0.18% 65
2021
Q3 		$315K Buy
+2,170
New +$318K 0.07% 147
2018
Q3 		– Sell
-60
Closed -$7K – 322
2018
Q2 		$7K Hold
60
– – ﹤0.01% 588
2018
Q1 		$6K Hold
60
– – ﹤0.01% 630
2017
Q4 		$6K Buy
+60
New +$5.69K ﹤0.01% 690

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Gryphon Financial Partners's DGX Position: Q2 2026 in Review

Gryphon Financial Partners increased its Quest Diagnostics (DGX) stake by 2.6% in Q2 2026, buying an estimated $9.42K and bringing the position to 1,861 shares worth $394K. The position accounts for 0.03% of the portfolio, ranked #266.

Gryphon Financial Partners first reported a position in DGX in Q4 2017 and has held it in 23 quarters since. The position peaked at $951K in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Gryphon Financial Partners held 1,861 shares of Quest Diagnostics worth $394K as of Q2 2026.
  • Gryphon Financial Partners bought 48 Quest Diagnostics shares in Q2 2026, an estimated $9.42K.
  • Quest Diagnostics made up 0.03% of Gryphon Financial Partners's portfolio in Q2 2026, its #266 holding.
  • Gryphon Financial Partners first reported a position in Quest Diagnostics in Q4 2017 and has held it in 23 quarters since.
  • Gryphon Financial Partners's Quest Diagnostics position peaked at $951K in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.